| Drug Name: | Terazosin (63590-64-7) |
|---|---|
| PubChem ID: | 5401 |
| SMILES: | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC |
| InchiKey: | VCKUSRYTPJJLNI-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Neurotransmitter Agents, Urological Agents |
| Molecular Weight (dalton) | : | 387.44 |
| LogP | : | 1.0568 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 103.04 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category